The market for multiple sclerosis drugs and treatment is anticipated to grow at a significant CAGR of about 6% during the forecast period, i.e., 2019-2027.
nutraceutical packaging is estimated to witness a significant growth by expanding at a notable CAGR of around 4.8% during the forecast period of 2019-2027.